Frederick R Ahmann

  • 4529 Citations
  • 31 h-Index
1979 …2017

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Frederick R Ahmann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • PHASE II CHEMOPREVENTION TRIAL OF SE AND PROSTATE CANCER

    Ahmann, F. R., Marshall, J. & Clark, L.

    National Institutes of Health

    9/30/988/31/09

    Project: Research project

  • Research Output

    • 4529 Citations
    • 31 h-Index
    • 80 Article
    • 3 Chapter
    • 3 Review article
    • 2 Letter

    Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men

    Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, ML. A., Scardino, P. T., Flanigan, R. C., DeKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. & Southwick, P. C., Feb 1 2017, In : Journal of Urology. 197, 2, p. S200-S207

    Research output: Contribution to journalArticle

  • 23 Scopus citations

    Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer

    Algotar, A. M., Stratton, M. S., Ahmann, F. R., Ranger-Moore, J., Nagle, R. B., Thompson, P. A., Slate, E., Hsu, C. H., Dalkin, B. L., Sindhwani, P., Holmes, M. A., Tuckey, J. A., Graham, D. L., Parnes, H. L., Clark, L. C. & Stratton, S. P., Feb 15 2013, In : Prostate. 73, 3, p. 328-335 8 p.

    Research output: Contribution to journalArticle

  • 58 Scopus citations

    A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

    Tolcher, A. W., Quinn, D. I., Ferrari, A., Ahmann, F., Giaccone, G., Drake, T., Keating, A. & De Bono, J. S., Apr 1 2012, In : Annals of Oncology. 23, 4, p. 968-973 6 p.

    Research output: Contribution to journalArticle

  • 94 Scopus citations

    Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity

    Algotar, A. M., Thompson, P. A., Ranger-Moore, J., Stratton, M. S., Hsu, C. H., Ahmann, F. R., Nagle, R. B. & Stratton, S. P., Apr 1 2012, In : Internal Medicine Journal. 42, 4, p. 374-380 7 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations
  • 85 Scopus citations